Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPAVEHDI: Corticosteroids vs Corticosteroids + ECP for Grade II Acute GVHD
NCT06133192Phase 2Not yet recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jan 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in Acute Graft-Versus-Host Disease (aGvHD), sponsored by CHRU de Nancy - Hôpital Central. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
methoxsalen
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT06133192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06133192.